Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Learn what leads to budget failure and how to install safeguards, so your plan survives spikes in income or expenses.
8,421 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
If Vertex pursues Crinetics, what would it mean for the stock? This article breaks down potential value, risks, and t...
What if SpaceX and xAI merged to run data centers in orbit? This article breaks down how orbital compute could work, ...
AST SpaceMobile has fallen from its highs even after a sizable funding round. This article explains why the fade in s...
CEOs confront a defining moment as AI and rapid tech adoption reshape how growth and work interact. This report outli...
Many retirees have a big asset in their home, but counting home equity fund as retirement income is a risky move. Thi...
Mega-cap tech values are under pressure, and the question on many minds is whether Alphabet, Apple, Microsoft kicked ...
Are the best-known stocks truly a massive opportunity or a trap built by hype? This guide breaks down 10 popular name...
A sharp move lower in Carnival Corporation stock sank today as investors weigh macro headwinds against the cruise ope...
XRP is mired in a short-term pullback as buyers hesitate near $1.40. With two red weekly candles, analysts flag a pot...
Ethereum eyes a critical support level as traders monitor a potential breakout. If the level holds, ethereum (eth) co...
XRP rose about 5% this week but stays trapped under key thresholds, leaving traders watching critical levels for a br...